Εμφανίζονται 1 - 20 Αποτελέσματα από 74 για την αναζήτηση '"СИНДРОМ СИСТЕМНОЙ ВОСПАЛИТЕЛЬНОЙ РЕАКЦИИ"', χρόνος αναζήτησης: 0,89δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    Πηγή: Obstetrics, Gynecology and Reproduction; Vol 18, No 5 (2024); 743-753 ; Акушерство, Гинекология и Репродукция; Vol 18, No 5 (2024); 743-753 ; 2500-3194 ; 2313-7347

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/2196/1252; Simonsen K.A., Anderson-Berry L.N., Delair S.F. et al. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27(1):21–47. https://doi.org/10.1128/CMR.00031-13.; Боронина Л.Г., Саматова Е.В., Пруткин М.Е. Расширение возможностей в диагностике бактериемии и сепсиса у детей многопрофильного стационара. Клиническая лабораторная диагностика. 2019;64(10):613–9. https://doi.org/10.18821/0869-2084-2019-64-10-613-619.; Анохин В.А., Халиуллина С.В., Назарова О.А., Хаертынов Х.С. Случай раннего неонатального сепсиса, обусловленного Corynebacterium amycolatum. Практическая медицина. 2012;7(62):178–80.; Карпова А.Л., Ковалева М.А., Карпов Н.Ю. и др. Врожденная инфекция, вызванная вирусом SARS-CoV-2: обзор литературы и первое клиническое наблюдение у недоношенного новорожденного ребенка в России. Педиатрия имени Г.Н. Сперанского. 2022;101(1):209–14. https://doi.org/10.24110/0031-403X-2022-101-1-209-214.; Карпова А.Л., Мостовой А.В., Мартиросян С.В. и др. Ранний неонатальный сепсис, вызванный Haemophilus influenzae. Акушерство, Гинекология и Репродукция. 2023;17(3):366–75. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.415.; Diekema D.J., Pfaller M.A., Jones R.N. et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents. 2000;13(4):257–71. https://doi.org/10.1128/spectrum.01462-21.; Fluit A.C., Jones M.E., Schmitz F.J. et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program 1997 and 1998. Clin Infect Dis. 2000;30(3):454–60. https://doi.org/10.1086/313710.; Barry R., Houlihan E., Knowles S.J. et al. Antenatal pyelonephritis: a three-year retrospective cohort study of two Irish maternity centres. Eur J Clin Microbiol Infect Dis. 2023;42(7):827–33. https://doi.org/10.1007/s10096-023-04609-6.; Unhanand M., Mustafa M.M., McCracken G.H., Nelson J.D. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr. 1993;122(1):15–21. https://doi.org/10.1016/S0022-3476(05)83480-8.; Sikias P., Biran V., Foix-L'Hélias L. et al.; EOS study group. Early-onset neonatal sepsis in the Paris area: a population-based surveillance study from 2019 to 2021. Arch Dis Child Fetal Neonatal Ed. 2023;108(2):114–20. https://doi.org/10.1136/archdischild-2022-324080.; Nabi S.N., Basak A.K., Kamruzzaman M. et al. Performance of haematological parameters in early diagnosis of clinically suspected neonatal sepsis. Mymensingh Med J. 2019;28(1):193–9.; Shabaan A.E., Elbaz L.M., El-Emshaty W.M., Shouman B. Role of serum (1,3)-β-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit. J Pediatr (Rio J). 2018;94(5):559–65. https://doi.org/10.1016/j.jped.2017.07.020.; Boulos A., Rand K., Johnson J.A. et al. Neonatal sepsis in Haiti. J Trop Pediatr. 2017;63(1):70–3. https://doi.org/10.1093/tropej/fmw077.; Hervás J.A., Ciria L., Henales V. et al. Nonsurgical management of neonatal multiple brain abscesses due to Proteus mirabilis. Helv Paediatr Acta. 1987;42(5–6):451–6.; Casadevall I., Betremieux P., Donnio P.Y. et al. Neonatal Proteus mirabilis septicemia and cerebral abscess. Value of the assay of antibiotics in the puncture fluid. Pediatrie. 1989;44(2):97–101. (In French).; Omoruyi E.A., Evangelista M. Proteus mirabilis septicemia and meningitis in a neonate. J Med Cases. 2014;5(4):245–7. https://doi.org/10.14740/jmc1290w.; Darby C.P., Conner E., Kyong C.U. Proteus mirabilis brain abscess in a neonate. Dev Med Child Neurol. 1978;20(3):366–8. https://doi.org/10.1111/j.1469-8749.1978.tb15226.x.; Okubo T., Shirane R., Mashiyama S. Proteus mirabilis brain abscess in a neonate. No Shinkei Geka. 1984;12(3 Suppl):395–400. (In Japanese).; Carre M., Sarlangue J., Baronnet R. et al. Cerebral abscess caused by Proteus mirabilis in the neonatal period. Arch Fr Pediatr. 1987;44(10):871–4. (In French).; Chung M.H., Kim G., Han A., Lee L. Case report of neonatal Proteus mirabilis meningitis and brain abscess with negative initial image finding: Consideration of serial imaging studies. Neonatal Med. 2017;24(4):187–91. https://doi.org/10.5385/nm.2017.24.4.187.; Lizardo-Barahona J.R., Nieto-Zermeño J., Bracho-Blanchet E. Adrenal abscess in the newborn: a case report and review of the literature. Bol Med Hosp Infant Mex. 1990;47(6):401–4. (In Spanish).; Hashmi M.A., Lodhi M.A., Toor K.M. et al. Emerging antimicrobial resistance in neonatal sepsis. J Coll Physicians Surg Pak. 2020;30(12):1312–5. https://doi.org/10.29271/jcpsp.2020.12.1312.; Ballot D.E., Bandini R., Nana T. et al. A review of-multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa. BMC Pediatr. 2019;19(1):320. https://doi.org/10.1186/s12887-019-1709-y.; Aku F.Y., Akweongo P., Nyarko K. et al. Bacteriological profile and antibiotic susceptibility pattern of common isolates of neonatal sepsis, Ho Municipality, Ghana-2016. Matern Health Neonatol Perinatol. 2018;4:2. https://doi.org/10.1186/s40748-017-0071-z.; Jain S., Gaind R., Kothari C. et al. VEB-1 extended-spectrum β-lactamase-producing multidrug-resistant Proteus mirabilis sepsis outbreak in a neonatal intensive care unit in India: clinical and diagnostic implications. JMM Case Rep. 2016;3(4):e005056. https://doi.org/10.1099/jmmcr.0.005056.; Ahmad A., Sarwar N., Aslam R. et al. Pattern of clinical drug resistance and occurrence of Gram negative bacterial neonatal sepsis at a tertiary care hospital. Pak J Pharm Sci. 2021;34(5(Supplementary)):1873–8.; Ullah O., Khan A., Ambreen A. et al. Antibiotic sensitivity pattern of bacterial isolates of neonatal septicemia in Peshawar, Pakistan. Arch Iran Med. 2016;19(12):866–9.; Silverman W.A., Andersen D.H. A controlled clinical trial of effects of water mist on obstructive respiratory signs, death rate and necropsy findings among premature infants. Pediatrics. 1956;17(1):1–10.; Cetinkaya M., Köksal N., Özkan H. A new scoring system for evaluation of multiple organ dysfunction syndrome in premature infants. Am J Crit Care. 2012;21(5):328–37. https://doi.org/10.4037/ajcc2012312.; Мостовой А.В., Карпова А.Л. Искусственная вентиляция легких у новорожденных: физиологические особенности газообмена и механики дыхания как основа для управления параметрами вентиляции. Детские болезни сердца и сосудов. 2016;13(2):79–87.; Карпова А.Л., Мостовой А.В., Прутко Е.Е. и др. Интерлейкин-6 как индикатор тяжести полиорганной недостаточности у недоношенных детей с массой тела менее 1500 г: ретроспективное когортное исследование. Педиатрия имени Г.Н. Сперанского. 2023;102(1):54–63. https://doi.org/10.24110/0031-403X-2023-102-1-54-63.; Eichberger J., Resch E., Resch B. Diagnosis of neonatal sepsis: the role of inflammatory markers. Front Pediatr. 2022;10:840288. https://doi.org/10.3389/fped.2022.840288.; Qiu X., Zhang L., Tong Y. et al. Interleukin-6 for early diagnosis of neonatal sepsis with premature rupture of the membranes: A meta-analysis. Medicine (Baltimore). 2018;97(47):e13146. https://doi.org/10.1097/MD.0000000000013146.; Бронхолегочная дисплазия. Монография. Под ред. Д.Ю. Овсянникова, Н.А. Геппе, А.Б. Малахова, Д.Н. Дегтярева. М., 2020. 175 c.; Мостовой А.В., Карпова А.Л., Попов И.В. и др. Лаваж легких сурфактантом при неонатальном синдроме аспирации мекония как жизнеспасающая респираторная стратегия: клинический случай. Акушерство, Гинекология и Репродукция. 2024;18(4):581–95. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.533.; Berger C., Uehlinger J., Ghelfi D. et al. Comparison of C-reactive protein and white blood cell count with differential in neonates at risk for septicaemia. Eur J Pediatr. 1995;154(2):138–44. https://doi.org/10.1007/BF01991918.; Jurges E.S., Henderson D.C. Inflammatory and immunological markers in preterm infants: correlation with disease. Clin Exp Immunol. 1996;105(3):551–5. https://doi.org/10.1046/j.1365-2249.1996.d01-789.x.; Chiesa C., Fabrizio S., Assumma M. et al. Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders. Clin Chem. 2001;47(6):1016–22.; Benitz W.E. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol. 2010;37(2):421–38. https://doi.org/10.1016/j.clp.2009.12.001.; Bancalari E., Claure N., Sosenko I.R. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 2003;8(1):63–71. https://doi.org/10.1016/s1084-2756(02)00192-6.; Schuchat A., Dowell S.F. Pneumonia in children in the developing world: new challenges, new solutions. Semin Pediatr Infect Dis. 2004;15(3):181–9. https://doi.org/10.1053/j.spid.2004.05.010.; Puopolo K.M., Benitz W.E., Zaoutis T.E.; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES. Management of neonates born at ≤ 34 6/7 weeks' gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142(6):e20182896. https://doi.org/10.1542/peds.2018-2896.; https://www.gynecology.su/jour/article/view/2196

  3. 3
  4. 4
  5. 5
  6. 6
    Academic Journal

    Συνεισφορές: Russian Science Foundation (project № 18-15-00153), Исследование выполнено за счет гранта Российского научного фонда (проект № 18-15-00153)

    Πηγή: Medical Immunology (Russia); Том 23, № 5 (2021); 1089-1104 ; Медицинская иммунология; Том 23, № 5 (2021); 1089-1104 ; 2313-741X ; 1563-0625

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.mimmun.ru/mimmun/article/view/2166/1472; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7261; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7262; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7265; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7266; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7267; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7268; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7269; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7270; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7271; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7272; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7273; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7274; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2166/7275; Борщев Ю.Ю., Буровенко И.Ю., Карасева А.Б., Минасян С.М., Борщев В.Ю., Семенова Н.Ю., Борщева О.В., Половинкин В.В., Родионов Г.Г., Суворов А.Н., Галагудза М.М. Моделирование синдрома системной воспалительной реакции химической индукцией травмы толстого кишечника у крыс // Медицинская иммунология, 2020. T. 22, № 1. С. 87-98. doi:10.15789/1563-0625-MOS-1839.; Борщев Ю.Ю., Ермоленко Е.И. Метаболический синдром и микроэкология кишечника // Трансляционная медицина, 2014. № 1. С. 19-28.; Королев Д.В., Александров И.В., Галагудза М.М., Сыренский А.В., Сонин Д.Л., Егорова Е.И. Автоматизация получения и обработки данных физиологического эксперимента // Регионарное кровообращение и микроциркуляция, 2008. Т. 7, № 2 (26). С. 79-84.; Минасян С.М., Бадриханова Л.Р., Галагудза М.М., Курапеев Д.И. Сравнительное исследование защитного эффекта гипотермии, ишемического прекондиционирования и модифицированных кардиоплегических растворов при ишемии-реперфузии изолированного сердца крысы // Регионарное кровообращение и микроциркуляция, 2008. Т. 7, № 2 (26). С. 72-78.; Москалев А.В., Рудой А.С., Апчел А.В., Зуева В.О., Казымова О.Э. Особенности биологии трансформирующего ростового фактора в и иммунопатология // Вестник российской военно-медицинской академии, 2016. № 2 (54). С. 206-216.; Серебряная Н.Б., Липатова Л.В., Сивакова Н.А., Василенко А.В. Рекомбинантный интерлейкин IL-2 человека как агент антиэпилептической терапии // Российский иммунологический журнал, 2014. Т. 8, № 3. С. 723-726.; Симбирцев А.С. Интерлейкин-2 и рецепторный комплекс интерлейкина-2 в регуляции иммунитета // Иммунология, 1998. № 3. С. 3-8.; Симбирцев А.С. Интерлейкин-8 и другие хемокины // Иммунология, 1999. № 4. С. 9-14.; Уголев А.М. Мембранное пищеварение. Полисубстратные процессы, организация и регуляция. Л.: Наука, 1972. 356 с.; Фомичева Е.Е., Шанин С.Н., Филатенкова Т.А., Серебряная Н.Б. IL-2 как регулятор уровней стресс-гормонов и нейротропного фактора BDNF при экспериментальной черепно-мозговой травме // Медицинская иммунология, 2020. Т. 22, № 4. С. 647-656. doi:10.15789/1563-0625-IAR-1973.; Abbas A.K., Trotta E., Simeonov D., Marson A., Bluestone J.A. Revisiting IL-2: Biology and therapeutic prospects. Sci. Immunol., 2018, Vol. 3, Iss. 25, pii: eaat1482. doi:10.1126/sciimmunol.aat1482.41.; Alhazmi A., Stojanovski E., McEvoy M., Garg M.L. Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies. J. Am. Coll. Nutr., 2012, no. 31, pp. 243-258.; Braun E.S., Crawford F.W., Desai M.M., Meek J., Kirley P.D., Miller L., Anderson E.J., Oni O., Ryan P., Lynfield R., Bargsten M., Bennett N.M., Lung K.L., Thomas A., Mermel E., Lindegren M.L., Schaffner W., Price A., Chaves S.S. Obesity not associated with severity among hospitalized adults with seasonal influenza virus infection. Infection, 2015, Vol. 43, no. 5, pp. 569-575.; Carrero J.J., Park S.H., Axelsson J., Lindholm B., Stenvinkel P. Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: a dreadful triad. Semin Dial., 2009, Vol. 22, no. 4, pp. 381-386.; Chowdhury R., Warnakula S., Kunutsor S., Crowe F., Ward H.A., Johnson L., Franco O.H., Butterworth A.S., Forouhi N.G., Thompson S.G., Khaw K.T., Mozaffarian D., Danesh J., Di Angelantonio E. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann. Intern. Med., 2014, no. 160, pp. 398-406.; Degirolamo C., Shelness G.S., Rudel L.L. LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J. Lipid Res., 2009, 50 Suppl. (Suppl.), pp. 434-439.; Jakobsen M.U., Dethlefsen C., Joensen A.M., Stegger J., Tj0nneland A., Schmidt E.B., Overvad K. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am. J. Clin. Nutr., 2010, Vol. 91, no. 6, pp. 1764-1768.; Dietary Guidelines Advisory Committee; Scientific Report of the 2015 Dietary Guidelines Advisory Committee, 2015. Available at: http://www.health.gov/dietaryguidelines/2015-scientific-report/.; Dinarello CA. Proinflammatory cytokines. Chest, 2000, Vol. 118, no. 2, pp. 503-508.; Dinarello C.A., Cannon J.G., Mier J.W., Bernheim H.A., LoPreste G., Lynn D.L., Love R.N., Webb A.C., Auron P.E., Reuben R.C. Multiple biological activities of human recombinant interleukin 1. J. Clin. Invest., 1986, Vol. 77, no. 6, pp. 1734-1739.; Fahey T.J. 3rd, Sherry B., Tracey K.J., van Deventer S., Jones W.G. 2nd, Minei J.P., Morgello S., Shires G.T., Cerami A. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine, 1990, Vol. 2, no. 2, pp. 92-99.; Frieden T.R., Berwick D.M. The “Million Hearts” initiative - preventing heart attacks and strokes. N. Engl. J. Med., 2011, Vol. 365, no. 13, e27. doi:10.1097/01.NPR.0000476372.04620.7a.; Geleijnse J.M., de Goede J., Brouwer I.A. Alpha-linolenic acid: is it essential to cardiovascular health? Curr. Atheroscler. Rep., 2010, no. 12, pp. 359-367.; Himmerich H., Fischer J., Bauer K., Kirkby K.C., Sack U., Krugel U. Stress-induced cytokine changes in rats. Eur. Cytokine Netw., 2013, Vol. 24, no. 2, pp. 97-103.; Huttunen R., Karppelin M., Syrjanen J. Obesity and nosocomial infections. J. Hosp. Infect., 2013, Vol. 85, no. 1, pp. 8-16.; Jakobsen M.U., O'Reilly E.J., Heitmann B.L., Pereira M.A., Balter K., Fraser G.E., Goldbourt U., Hallmans G., Knekt P., Liu S., Pietinen P., Spiegelman D., Stevens J., Virtamo J., Willett W.C., Ascherio A. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr., 2009, no. 89, pp. 1425-1432.; James W.P.T., Jackson-Leach R., Mhurchu C.N., Kalamara E., Shayeghi M., Rigby N.J., Nishida C., Rodgers A. Overweight and obesity (high body mass index). In: Ezzati M et al., eds. Comparative quantification of health risks: global and regional burden of disease attribution to selected major risk factors, Vol. 1. Geneva, World Health Organization, 2004, pp. 497-596.; Kaspersen K.A., Pedersen O.B., Petersen M.S., Hjalgrim H., Rostgaard K., M0ller B.K., Juul-S0rensen C., Kotze S., Dinh K.M., Erikstrup L.T., S0rensen E., Th0rner L.W., Burgdorf K.S., Ullum H., Erikstrup C. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology, 2015, Vol. 26, no. 4, pp. 580-589.; Kumar M., Dhaka P., Vijay D., Vergis J., Mohan V., Kumar A., Kurkure N.V., Barbuddhe S.B., Malik S.V., Rawool D.B. Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrugresistant enteroaggregative Escherichia coli. Int. J. Antimicrob. Agents, 2016, Vol. 48, no. 3, pp. 265-270.; Marmot M., Wilkinson R., eds. Social Determinants of Health. 2nd edition ed. Oxford University Press, 2005. Available at: https://oxford.universitypressscholarship.com/view/10.1093/acprof:oso/9780198565895.001.0001/acprof-9780198565895.; Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med., 2010, no. 7, e1000252. doi:10.1371/journal.pmed.1000252.; Mozaffarian D. Diverging global trends in heart disease and type 2 diabetes: the role of carbohydrates and saturated fats. Lancet Diabetes Endocrinol., 2015, Vol. 3, no. 8, pp. 586-588.; Pan A., Chen M., Chowdhury R., Wu J.H., Sun Q., Campos H., Mozaffarian D., Hu F.B. alpha-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am. J. Clin. Nutr., 2012, no. 96, pp. 1262-1273.; Peveri P., Walz A., Dewald B., Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med., 1988, Vol. 167, pp. 1547-1259.; Prentice A.M., Jebb S.A. Energy intake/physical activity interactions in the homeostasis of body weight regulation. Nutr. Rev., 2004, Vol. 62, pp. S98-S104.; Sato Y., Ohshima T. The expression of mRNA of proinflammatory cytokines during skin wound healing in mice: a preliminary study for forensic wound age estimation (II). Int. J. Legal. Med., 2000, Vol. 113, pp. 140-145.; Schroeder J., Mrowietz U., Morita E., Christophers E. Purification and biochemical characterization of a human monocyte derived neutrophil activating peptide that lacks interleukin-1 activity. J. Immunol., 1987, Vol. 139, pp. 3474-3483.; Schwingshackl L., Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and metaanalysis of cohort studies. Lipids Health Dis., 2014, Vol. 13, 154.; Seidell J.C. Dietary fat and obesity: an epidemiologic perspective. Am. J. Clin. Nutr., 1998, Vol. 67 (Suppl. 3), pp. 546S-550S.; Storlien L.H., Huang X.F., Lin S., Xin X., Wang H.Q., Else P.L. Dietary fat subtypes and obesity. World Rev. Nutr. Diet., 2001, Vol. 88, pp. 148-154.; Tordjman J., Guerre-Millo M., Clement K. Adipose tissue inflammation and liver pathology in human obesity. Diabetes Metab., 2008, Vol. 34, no. 6 (Pt 2), pp. 658-663.; Ulich T.R., Yin S., Guo K., Yi E.S., Remick D., del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol., 1991, Vol. 138, no. 5, pp. 1097-1101.; US Food and Drug Administration, FDA Cuts Trans Fat in Processed Foods, 2015. Available at: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm372915.htm.; Utzolino S., Ditzel C.M., Baier P.K., Hopt U.T., Kaffarnik M.F. The obesity paradox in surgical intensive care patients with peritonitis. J. Crit. Care, 2014, Vol. 29, no. 5, pp. 887.e1-5.; Visscher T.L., Seidell J.C. The public health impact of obesity. Annu. Rev. Public Health, 2001, Vol. 22, pp. 355-375.; Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev., 2003, Vol. 83, pp. 835-870.; Wu J.H., Micha R., Imamura F., Pan A., Biggs M.L., Ajaz O., Djousse L., Hu F.B., Mozaffarian D. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br. J. Nutr., 2012, Vol. 107, Suppl. 2, pp. S214-S227.; https://www.mimmun.ru/mimmun/article/view/2166

  7. 7
  8. 8
  9. 9
    Academic Journal

    Πηγή: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 14, № 3 (2017); 51-57 ; Вестник анестезиологии и реаниматологии; Том 14, № 3 (2017); 51-57 ; 2541-8653 ; 2078-5658

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.vair-journal.com/jour/article/view/161/199; Ефремов С. М., Покушалов Е. А., Романов А. Б. и др. Исследование антиаритмических эффектов полиненасыщенных жирных кислот в кардиохирургии. Данные имплантируемого монитора ритма сердца // Патология кровообращения и кардиохирургия. − 2014. – Т. 18, № 3. – С. 12−18.; Филипповская Ж. С., Герасименко О. Н., Гребенчиков О. А. и др. Оксидантный стресс и ранние осложнения послеоперационного периода в кардиохирургии // Вестн. анестезиол. и реаниматол. − 2016. – Т. 13, № 6. – С. 13−21.; Arterburn L. M., Hall E. B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans // Am. J. Clin. nutrition. − 2006. – Vol. 83 (6 Suppl.). − P. 1467S−1476S.; Bang H. O., Dyerberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos // Acta Med. Scandinavica. – 1976. – Vol. 200, № 1−2. – P. 69−73.; Bays H. E. Safety considerations with omega-3 fatty acid therapy // Am. J. Cardiol. – 2007. – Vol. 99. – P. 35−43.; Benjamin E. J., Blaha M. J., Chiuve S. E. On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association // Circulation. – doi:10.1161/CIR.0000000000000485; Calò L., Bianconi L., Colivicchi F. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial // J. Am. Coll Cardiol. – 2005. – Vol. 17, № 45. – P. 1723−1728.; Carpentier Y. A., Dupont I. E. Advances in intravenous lipid emulsions // World J. Surg. – 2000. – Vol. 24. – P. 1493–1497.; Charman A., Muriithi E. W., Milne E. et al. Fish oil before cardiac surgery: neutrophil activation is unaffected but myocardial damage is moderated //; Prostaglandins Leukot Essent Fatty Acids. – 2005. – Vol. 72, № 4. – P. 257−265.; Daren K. H., Lukan J. K., McClave S. A. The role of nutritional support in sepsis // Springer US, The Sepsis Text. – 2002. – P. 479−490, ISBN 978-0-306-47664-8.; Duvall M. G., Levy B. D. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation // Eur. J. Pharmacol. – 2016. – Vol. 15, № 785. – P. 144−155.; Friedman A., Moe S. Review of the effects of omega-3 supplementation in dialysis patients // Clin. J. Am. Society Nephrology. – 2006. – Vol. 1. – P. 182–192.; Harris W. S. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? // Am. J. Cardiol. – 2007. – Vol. 19, № 99. – P. 44C−46C.; Kantarci A., Van Dyke T. E. Lipoxins in chronic inflammation // Critical reviews in oral biology and medicine: an official publication of the American Association of Oral Biologists. – 2003. – Vol. 14, № 1. – P. 4.; Klek S., Kulig J., Sierzega M. et al. The impact of immunostimulating nutrition on infectious complications after upper gastrointestinal surgery: a prospective, randomized, clinical trial // Ann. Surgery. – 2008. – Vol. 248, № 2. – P. 212−220.; Kloner R. A., Jennings R. B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1 // Circulation. – 2001. – Vol. 104, № 24. – P. 2981−2989.; Koster S., Oosterveld F. G., Hensens A. G. et al. Delirium after cardiac surgery and predictive validity of a risk checklist // Ann. Thoracic Surgery. – 2008. – Vol. 86, № 6. – P. 1883−1887.; Laffey J. G., Boylan J. F., Cheng D. C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist // Anesthesiology. – 2002. – Vol. 97, № 1. – P. 215−252.; Li X. L., Steiner M. Fish oil: a potent inhibitor of platelet adhesiveness // Blood. – 1990. – Vol. 76. – P. 938−945.; Marchioli R., Barzi F., Bomba E. et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione // Circulation. – 2002. – Vol. 105. – P. 1897–1903.; Mariani J., Doval H. C., Nul D. et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials // J. Am. Heart Association. – 2013. – Vol. 2, № 1. – e005033.; Manzanares W., Langlois P. L., Dhaliwal R. et al. Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis // Crit. Care. – 2015. – Vol. 19. – P. 167.; Mayer K., Gokorsch S., Fegbeutel C. et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis // Am. J. Respire. Crit. Care Med. – 2003. – Vol. 167, № 10. – P. 1321−1328.; McGowan F. X., Ikegami M., Nido P. J. et al. Cardiopulmonary bypass significantly reduces surfactant activity in children // J. Thorac. Cardiovasc. Surg. – Vol. 106, № 1993. – P. 968–977.; Montgomery P., Richardson A. J. Omega-3 fatty acids for bipolar disorder // Cochrane database of systematic reviews. – 2008. – Vol. 2. – CD005169.; Mozaffarian D., Marchioli R., Gardner T. et al. The ω-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) trial-rationale and design // Am. Heart J. – 2011. – Vol. 162, № 1. – P. 56−63.; Mozaffarian D., Wu J. H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events // J. Am. College Cardiology. – 2011. – Vol. 58, № 20. – P. 2047−2067.; Ott J., Hiesgen C., Mayer K. Lipids in critical care medicine // Prostaglandins, leukotrienes, and essential fatty acids. – 2011. – Vol. 85, № 5. – P. 267−273.; Ovize M., Baxter G. F., Di Lisa F. et al. Postconditioning and protection from reperfusion injury: where do we stand? // Cardiovasc. Res. – 2010. – Vol. 87. – P. 406−423.; Parish M., Valiyi F., Hamishehkar H. et al. The effect of Omega-3 fatty acids on ARDS: A Randomized Double-Blind Study // Advanced Pharmaceutical Bulletin. – 2014. – Vol. 4, Suppl. 2. – P. 555−561.; Pascal L., Langlois G. H., Manzanares W. ω-3 polyunsaturated fatty acids in cardiac surgery patients // J. Parenteral and Enteral Nutrition. – Vol. 41, Issue 2. – P. 152–154.; Pennock J., Pierce W., Waldhausen J. The management of the lungs during cardiopulmonary bypass // Surg. Gynecol Obstet. – 1977. – Vol. 145. – P. 917–927.; Pontes-Arruda A., Martins L. F., de Lima S. M. et al. Investigating nutritional therapy with EPA, GLA and antioxidants role in sepsis treatment (INTERSEPT) Study Group. Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study // Crit. Care. – 2011. – Vol. 9, № 15. – P. R144.; Plourde M., Cunnane S. C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements // Applied physiology, nutrition, and metabolism // Physiologie appliquee, nutrition et metabolisme. – 2007. – Vol. 32, № 4. – P. 619−634.; Rees A. M., Austin M. P., Parker G. B. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial // The Austral. New Zealand J. Psychiatry. – 2008. – Vol. 42, № 3. – P. 199−205.; Richard C. B., Smith J. E., Yeh Yu-Yan. The effects of dietary fish oil on alveolar type II cell fatty acids and lung surfactant phospholipids // Lipids March. – 1993. – Vol. 28, Is. 3. – P. 167–172.; Rizos E. C., Ntzani E. E., Bika E. et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis // JAMA. – 2012. – Vol. 308, № 10. – P. 1024−1033.; Roulet M., Frascarolo P., Pilet M. et al. Effects of intravenously infused fish oil on platelet fatty acid phospholipid composition and on platelet function in postoperative trauma // JPEN J. Parenteral Enteral Nutrition. – 1997. – Vol. 21, № 5. – P. 296−301.; Serhan C. N., Brain S. D., Buckley C. D. et al. Resolution of inflammation: state of the art, definitions and terms // FASEB journal: official publication of the Federation of American Societies for Experimental Biology. – 2007. – Vol. 21, № 2. – P. 325−332.; Simoens C. M., Deckelbaum R. J., Massaut J. J. et al. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids // Am. J. Clin. Nutrition. – 2008. – Vol. 88, № 2. – P. 282−288.; Suleiman M. S., Zacharowski K., Angelini G. D. Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics // British J. Pharmacology. – 2008. – Vol. 153, № 1. – P. 21−33.; Tsekos E., Reuter C., Stehle P. et al. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery // Clin. Nutrition. – 2004. – Vol. 23, № 3. – P. 325−330.; Thomas C. H., Dilraj K. B., Dhya Al-Leswas et al. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis // J. Parenteral and Enteral Nutrition. – Vol. 39, Issue 3. – P. 301–312.; Wanten G. J., Calder P. C. Immune modulation by parenteral lipid emulsions // Am. J. Clin. Nutrition. – 2007. – Vol. 85, № 5. – P. 1171−1184.; Yang G., Xue X., Chen Y. et al. Effects of cardiopulmonary bypass on lung nuclear factor-kappa B activity, cytokine release, and pulmonary function in dogs // Iranian J. Basic Med. Sciences. – 2015. – Vol. 18, № 12. – P. 1233−1242.

  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20